何丽娟, 殷春许, 张岭, 何廷贵, 司淑敏, 高亮. 125I粒籽植入放射工作人员受照剂量评估[J]. 中国辐射卫生, 2019, 28(2): 139-142,147.
HE Lijuan, YIN Chunxu, ZHANG Ling, HE Tinggui, SI Shumin, GAO Liang. Evaluation of exposure dose to medical staff during brachytherapy by 125I source. , 2019, 28(2): 139-142,147.
[1] 耿建华,肖泽军,杨剑,等.125I粒子植入治疗前列腺癌过程中医护人员受照水平的研究[J].中国医学装备,2014, 11(10):23-25. [2] Morris W J, Keyes M, Palma D, et al. Evaluation of dosimetric parameters and disease response after 125iodine transperineal brachytherapy for low-and intermediate-risk prostate cancer[J].Intermational Journal of Radiation Oncology Biology Physics, 2009, 73(5):1432-1438. [3] 耿建华,曹仲年,赵卫强,等.125I粒子装载过程中工作人员受照剂量的研究[J].中国医学装备,2012, 9(10):1-3. [4] 叶克强,黄明伟,李君利,等. 125I放射性粒子在骨介质中剂量分布的蒙特卡罗模拟[J].北京大学学报(医学版),2018, 50(1):131-135. [5] Pavlicek W, Walton H A, Karstaedt P J, et al. Radiation safety with use of 125I seeds for localization of nonpalpable breast lesions[J]. Academitc Radiology, 2006, l3(7):909-915. [6] Nath R, Anoderson L L, Luxton G, et al. Dosimetry of interstitial brachytherapy sources:recommendations of the AAPM tadiation therapy committee task group No.43[J]. Med Phys, 1995, 22(2):209-234. [7] Rivard M J, Coursey B M, DeWerd L A, et al. Update of AAPM Task Group No. 43 Report:A revised AAPM protocol for brachytherapy dose calculations[J]. Med Phys, 2004, 31(3):633-674. [8] Delacroix D, Guerre J P, Leblanc P, et al. Radionuclide and radiation protection data handbook 2002[J]. Radiation Protection Dosimetry, 2002, 98(1):9-168. [9] Meigooni A S, Gearheart D M, Sowards K. Experimental determination of dosimetric characteristics of Best 125I brachytherapy source[J]. Med Phys, 2000, 27(9):2168-2173. [10] 国际电工委员会.IEC 61066:2006热释光剂量测量系统用于个人和环境监测[S].瑞士,2006. [11] 薛娴,罗素明,何志坚,等.125I粒籽源植入中职业人员眼晶状体和手部受照剂量分析[J].中华放射医学与防护杂志,2018, 38(5):368-373.